Extendicare (OTCMKTS:EXETF) Trading Up 1.9% – Here’s What Happened

Extendicare Inc. (OTCMKTS:EXETFGet Free Report)’s stock price shot up 1.9% during mid-day trading on Monday . The stock traded as high as $19.58 and last traded at $19.58. 100 shares were traded during mid-day trading, a decline of 97% from the average session volume of 3,545 shares. The stock had previously closed at $19.2120.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on EXETF. Royal Bank Of Canada raised Extendicare from a “sector perform” rating to an “outperform” rating in a research note on Thursday, December 4th. National Bank Financial reissued an “outperform” rating on shares of Extendicare in a research note on Thursday, December 4th. Finally, BMO Capital Markets upgraded Extendicare from a “market perform” rating to an “outperform” rating in a report on Thursday, December 4th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy”.

View Our Latest Stock Analysis on Extendicare

Extendicare Stock Up 1.9%

The company’s fifty day simple moving average is $17.68 and its two-hundred day simple moving average is $14.48.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc (OTCMKTS:EXETF) is a Canada-based senior care provider headquartered in Markham, Ontario. The company specializes in the ownership and operation of long-term care homes, retirement residences and home health care services. It is publicly listed on the Toronto Stock Exchange under the symbol EXE and trades in the over-the-counter market as EXETF.

Extendicare’s operations are organized into two primary segments. The Long-Term Care & Retirement Living division operates approximately 120 facilities under the Extendicare and EspritVitalité banners, serving residents in Ontario, Alberta, Saskatchewan and parts of Atlantic Canada.

Further Reading

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.